XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Noncumulative Series B Preferred Stock
Noncumulative Convertible Preferred Stock Series C
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Preferred Stock A (Par Value: $0.01)
Common Stock (Par Value: $0.01)
Common Stock (Par Value: $0.01)
Series C Preferred Stock
Paid-in Capital in excess of Par
Paid-in Capital in excess of Par
Series B Preferred Stock
Paid-in Capital in excess of Par
Series C Preferred Stock
Paid-in Capital in excess of Par
Series D Preferred Stock
(Accumulated deficit)
Treasury Stock, at Cost
Accumulated Other Comprehensive Loss, Net of Tax
Beginning balance (in shares) at Dec. 31, 2022 [1] 227,072,445                              
Beginning balance at Dec. 31, 2022 $ 8,824           $ 503 $ 2   $ 8,135       $ 1,041 $ (237) $ (620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance and exercise of stock (in shares) [1] 13,010,669                              
Issuance and exercise of stock $ 85                 85            
Shares issued for restricted stock, net of forfeitures (in shares) [1] 1,174,473                              
Shares issued for restricted stock, net of forfeitures $ 0                 (31)         31  
Compensation expense related to restricted stock awards 33                 33            
Net (loss) income 2,626                         2,626    
Dividends paid on common stock (364)                         (364)    
Dividends paid on preferred stock $ (25)                         (25)    
Purchase of common stock (in shares) [1] (422,833)                              
Purchase of common stock $ (11)                           (11)  
Other comprehensive loss, net of tax $ (175)                             (175)
Ending balance (in shares) at Sep. 30, 2023 [2] 240,834,754                              
Ending balance at Sep. 30, 2023 $ 10,993           503 2   8,222       3,278 (217) (795)
Beginning balance at Dec. 31, 2022 0                              
Ending balance at Sep. 30, 2023 $ 0                              
Beginning balance (in shares) at Jun. 30, 2023 [2] 240,825,252                              
Beginning balance at Jun. 30, 2023 $ 11,060           503 2   8,209       3,205 (217) (642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Shares issued for restricted stock, net of forfeitures (in shares) [2] 43,458                              
Shares issued for restricted stock, net of forfeitures $ 0                              
Compensation expense related to restricted stock awards 13                 13            
Net (loss) income 207                         207    
Dividends paid on common stock (125)                         (125)    
Dividends paid on preferred stock $ (9)                         (9)    
Purchase of common stock (in shares) [2] (33,956)                              
Purchase of common stock $ 0                              
Other comprehensive loss, net of tax $ (153)                             (153)
Ending balance (in shares) at Sep. 30, 2023 [2] 240,834,754                              
Ending balance at Sep. 30, 2023 $ 10,993           503 2   8,222       3,278 (217) (795)
Beginning balance at Jun. 30, 2023 0                              
Ending balance at Sep. 30, 2023 $ 0                              
Beginning balance (in shares) at Dec. 31, 2023 [1] 240,688,790                              
Beginning balance at Dec. 31, 2023 $ 8,367           503 2   8,236       443 (218) (599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance and exercise of stock (in shares) [1] 25,543,655     63,770,655 85,435,618                      
Issuance and exercise of stock $ 103     $ 257 $ 341       $ 1 1 $ 257 $ 340   102    
Issuance of warrants to purchase common shares $ 302                 302            
Shares issued for restricted stock, net of forfeitures (in shares) [1] 275,051                              
Shares issued for restricted stock, net of forfeitures $ 0                 (9)         9  
Compensation expense related to restricted stock awards 38                 38            
Net (loss) income (930)                         (930)    
Dividends paid on common stock (48)                         (48)    
Dividends paid on preferred stock $ (27)                         (27)    
Purchase of common stock (in shares) [1] (455,802)                              
Purchase of common stock $ (10)                           (10)  
Other comprehensive loss, net of tax $ 178                             178
Ending balance (in shares) at Sep. 30, 2024 [2] 415,257,967                              
Ending balance at Sep. 30, 2024 $ 8,571           503 4   9,266       (562) (219) (421)
Beginning balance at Dec. 31, 2023 0                              
Preferred Stock Mezzanine (Par Value: $0.01)                                
Issuance of mezzanine preferred stock   $ 258 $ 346                          
Issuance of common shares for the conversion of Series B/ C preferred, net       $ (257) $ (346)                      
Ending balance at Sep. 30, 2024 $ 1                              
Beginning balance (in shares) at Jun. 30, 2024 [2] 351,304,364                              
Beginning balance at Jun. 30, 2024 $ 8,397           503 4   8,997       (270) (223) (614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance and exercise of stock (in shares) [2]       63,770,655                        
Issuance and exercise of stock       $ 257             $ 257          
Conversion of March 2024 Warrants to Series D preferred common equivalent shares           $ (302)             $ (302)      
Issuance of warrants to purchase common shares $ 302                 302            
Shares issued for restricted stock, net of forfeitures (in shares) [2] 282,417                              
Shares issued for restricted stock, net of forfeitures $ 0                 (5)         5  
Compensation expense related to restricted stock awards 17                 17            
Net (loss) income (280)                         (280)    
Dividends paid on common stock (3)                         (3)    
Dividends paid on preferred stock $ (9)                         (9)    
Purchase of common stock (in shares) [2] (99,469)                              
Purchase of common stock $ (1)                           (1)  
Other comprehensive loss, net of tax $ 193                             193
Ending balance (in shares) at Sep. 30, 2024 [2] 415,257,967                              
Ending balance at Sep. 30, 2024 $ 8,571           $ 503 $ 4   $ 9,266       $ (562) $ (219) $ (421)
Beginning balance at Jun. 30, 2024 258                              
Preferred Stock Mezzanine (Par Value: $0.01)                                
Issuance of common shares for the conversion of Series B/ C preferred, net       $ (257)                        
Ending balance at Sep. 30, 2024 $ 1                              
[1] On June 27, 2024, the Company announced a 1 for 3 reverse stock split, effective July 11, 2024. This reverse stock split is reflected retroactively in all periods presented. See Note 1 - Organization and Basis of Presentation.
[2] On June 27, 2024, the Company announced a 1 for 3 reverse stock split, effective July 11, 2024. This reverse stock split is reflected retroactively in all periods presented. See Note 1 - Organization and Basis of Presentation.